Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Fairclough SR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vidula N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. nvidula@mgh.harvard.edu., Rich TA; Guardant Health, Redwood City, California., Sartor O; Tulane Cancer Center, Tulane University, New Orleans, Louisiana., Yen J; Guardant Health, Redwood City, California., Hardin A; Guardant Health, Redwood City, California., Nance T; Guardant Health, Redwood City, California., Lilly MB; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Nezami MA; Pacific Medical Center of Hope, Fresno, California., Patel SP; University of California San Diego, Moores Cancer Center, La Jolla, California., Carneiro BA; Warren Alpert Medical School, Brown University, Lifespan Cancer Institute, Providence, Rhode Island., Fan AC; Stanford University School of Medicine, Stanford, California., Brufsky AM; University of Pittsburgh Magee Women's Hospital, Pittsburgh, Pennsylvania., Parker BA; University of California San Diego, Moores Cancer Center, La Jolla, California., Bridges BB; St Luke's Mountain States Tumor Institute, Meridian, Idaho., Agarwal N; University of Utah, Salt Lake City, Utah., Maughan BL; University of Utah, Salt Lake City, Utah., Raymond VM; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Lanman RB; Guardant Health, Redwood City, California., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Cristofanilli M; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 01; Vol. 26 (11), pp. 2546-2555. Date of Electronic Publication: 2020 Feb 07.
Autor:
Recondo G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Bahcall M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Spurr LF; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Leonardi GC; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Lo YC; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Li YY; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Nguyen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Umeton R; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Massachusetts Institute of Technology, Cambridge, Massachusetts., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Albayrak A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Cherniack AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Price KS; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Nishino M; Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Sholl LM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. mark_awad@dfci.harvard.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 01; Vol. 26 (11), pp. 2615-2625. Date of Electronic Publication: 2020 Feb 07.
Autor:
Willis J; The University of Texas MD Anderson Cancer Center, Houston, Texas., Lefterova MI; Guardant Health, Redwood City, California. mlefterova@guardanthealth.com., Artyomenko A; Guardant Health, Redwood City, California., Kasi PM; Division of Oncology/Hematology, Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Mody K; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Catenacci DVT; Department of Medicine, University of Chicago, Chicago, Illinois., Fakih M; Medical Oncology, City of Hope, Duarte, California., Barbacioru C; Guardant Health, Redwood City, California., Zhao J; Guardant Health, Redwood City, California., Sikora M; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Lee H; Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim KM; Division of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim ST; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim J; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Gavino D; INVITAE Corporation, San Francisco, California., Benavides M; Medical Oncology, Hospital Universitario Virgen de la Victoria, Malaga, Spain., Peled N; Division of Medical Oncology, Rabin Medical Center, Petach Tiqea, Israel., Nguyen T; Hematology/Oncology, Cleveland Clinic Foundation, Weston, Florida., Cusnir M; Comprehensive Cancer Center, Mount Sinai Medical Center, Miami Beach, Florida., Eskander RN; Center for Personalized Cancer Therapy, Division of Gynecologic Oncology, University of California San Diego Health Moores Cancer Center, La Jolla, California., Azzi G; Medical Oncology, Holy Cross Michael & Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Banks KC; Guardant Health, Redwood City, California., Raymond VM; Guardant Health, Redwood City, California., Lanman RB; Guardant Health, Redwood City, California., Chudova DI; Guardant Health, Redwood City, California., Talasaz A; Guardant Health, Redwood City, California., Kopetz S; The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee J; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Odegaard JI; Guardant Health, Redwood City, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 01; Vol. 25 (23), pp. 7035-7045. Date of Electronic Publication: 2019 Aug 04.
Autor:
Fairclough SR; Guardant Health, Inc., 505 Penobscot Dr, Redwood City, CA 94063 USA., Kiedrowski LA; Guardant Health, Inc., 505 Penobscot Dr, Redwood City, CA 94063 USA., Lin JJ; 2Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 USA., Zelichov O; NovellusDx, Jerusalem Biopark, Hadassah Ein-Kerem Medical Center Campus, Jerusalem, Israel., Tarcic G; NovellusDx, Jerusalem Biopark, Hadassah Ein-Kerem Medical Center Campus, Jerusalem, Israel., Stinchcombe TE; 4Duke Cancer Institute, DUMC 3198, 25178 Morris Building, Durham, NC 27710 USA., Odegaard JI; Guardant Health, Inc., 505 Penobscot Dr, Redwood City, CA 94063 USA., Lanman RB; Guardant Health, Inc., 505 Penobscot Dr, Redwood City, CA 94063 USA., Shaw AT; 2Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 USA., Nagy RJ; Guardant Health, Inc., 505 Penobscot Dr, Redwood City, CA 94063 USA.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2019 Oct 11; Vol. 8, pp. 24. Date of Electronic Publication: 2019 Oct 11 (Print Publication: 2019).
Autor:
Odegaard JI; Guardant Health, Redwood City, California. jodegaard@guardanthealth.com., Vincent JJ; Guardant Health, Redwood City, California., Mortimer S; Guardant Health, Redwood City, California., Vowles JV; Guardant Health, Redwood City, California., Ulrich BC; Dana-Farber Cancer Institute, Boston, Massachusetts., Banks KC; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Zill OA; Guardant Health, Redwood City, California.; Genentech, South San Francisco, California., Sikora M; Guardant Health, Redwood City, California., Mokhtari R; Guardant Health, Redwood City, California., Abdueva D; Guardant Health, Redwood City, California., Nagy RJ; Guardant Health, Redwood City, California., Lee CE; Guardant Health, Redwood City, California., Kiedrowski LA; Guardant Health, Redwood City, California., Paweletz CP; Dana-Farber Cancer Institute, Boston, Massachusetts., Eltoukhy H; Guardant Health, Redwood City, California., Lanman RB; Guardant Health, Redwood City, California., Chudova DI; Guardant Health, Redwood City, California., Talasaz A; Guardant Health, Redwood City, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Aug 01; Vol. 24 (15), pp. 3539-3549. Date of Electronic Publication: 2018 Apr 24.
Autor:
Zill OA; Guardant Health, Inc., Redwood City, California., Banks KC; Guardant Health, Inc., Redwood City, California., Fairclough SR; Guardant Health, Inc., Redwood City, California. sfairclough@guardanthealth.com., Mortimer SA; Guardant Health, Inc., Redwood City, California., Vowles JV; Guardant Health, Inc., Redwood City, California., Mokhtari R; Guardant Health, Inc., Redwood City, California., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, California., Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento, California., Odegaard JI; Guardant Health, Inc., Redwood City, California., Nagy RJ; Guardant Health, Inc., Redwood City, California., Baca AM; Guardant Health, Inc., Redwood City, California., Eltoukhy H; Guardant Health, Inc., Redwood City, California., Chudova DI; Guardant Health, Inc., Redwood City, California., Lanman RB; Guardant Health, Inc., Redwood City, California., Talasaz A; Guardant Health, Inc., Redwood City, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Aug 01; Vol. 24 (15), pp. 3528-3538. Date of Electronic Publication: 2018 May 18.
Autor:
Hu Y; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Alden RS; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Odegaard JI; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Chen R; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Heng J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Feeney N; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Nagy RJ; Guardant Health, Redwood City, California., Shah J; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey., Ulrich B; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gutierrez M; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey., Lanman RB; Guardant Health, Redwood City, California., Garber JE; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Geoffrey_oxnard@dfci.harvard.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Dec 01; Vol. 23 (23), pp. 7351-7359. Date of Electronic Publication: 2017 Sep 25.
Autor:
Sebé-Pedrós A; Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Barcelona, Catalonia, Spain., Burkhardt P, Sánchez-Pons N, Fairclough SR, Lang BF, King N, Ruiz-Trillo I
Publikováno v:
Molecular biology and evolution [Mol Biol Evol] 2013 Sep; Vol. 30 (9), pp. 2013-23. Date of Electronic Publication: 2013 Jun 14.
Autor:
Fairclough SR, Chen Z, Kramer E, Zeng Q, Young S, Robertson HM, Begovic E, Richter DJ, Russ C, Westbrook MJ, Manning G, Lang BF, Haas B, Nusbaum C, King N
Publikováno v:
Genome biology [Genome Biol] 2013 Feb 18; Vol. 14 (2), pp. R15. Date of Electronic Publication: 2013 Feb 18.